Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.610
+0.100 (2.85%)
At close: Nov 26, 2025
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.34 billion as of November 26, 2025. Its market cap has decreased by -40.76% in one year.
Market Cap
1.34B
Enterprise Value
1.26B
Revenue
9.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.61
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.34B, an increase of 249.57%. That is a compound annual growth rate of 34.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.34B | 0.39% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.35B |
| Pro Medicus | 27.17B |
| Cochlear | 17.87B |
| Sonic Healthcare | 11.63B |
| Ramsay Health Care | 7.33B |
| Ansell | 5.21B |
| Telix Pharmaceuticals | 4.72B |
| Mesoblast | 2.99B |